To develop an mRNA vaccine targeting C. perfringens alpha-toxin for preventing gas gangrene and enterotoxemia, we selected the CPA-CTD gene encoding the C-terminal domain (amino acids 247–370) of the alpha-toxin as the target, given that recombinant proteins of this fragment are non-toxic while retaining potential immunogenicity. Here, CPA1 is linked to gas gangrene.